Search Results - "van Veldhuisen, E."

Time-Dependent Impact of Irreversible Electroporation on Pancreas, Liver, Blood Vessels and Nerves: A Systematic Review of Experimental Studies by Vogel, J A, van Veldhuisen, E, Agnass, P, Crezee, J, Dijk, F, Verheij, J, van Gulik, T M, Meijerink, M R, Vroomen, L G, van Lienden, K P, Besselink, M G

“…Irreversible electroporation (IRE) is a novel ablation technique in the treatment of unresectable cancer. The non-thermal mechanism is thought to cause mostly…”
Get full text

Correction: Time-Dependent Impact of Irreversible Electroporation on Pancreas, Liver, Blood Vessels and Nerves: A Systematic Review of Experimental Studies by Vogel, J A, van Veldhuisen, E, Agnass, P, Crezee, J, Dijk, F, Verheij, J, van Gulik, T M, Meijerink, M R, Vroomen, L G, van Lienden, K P, Besselink, M G

“…[This corrects the article DOI: 10.1371/journal.pone.0166987.]…”
Get full text

Quantitative analysis of contribution of mild and moderate hyperthermia to thermal ablation and sensitization of irreversible electroporation of pancreatic cancer cells by Agnass, P., Rodermond, H.M., van Veldhuisen, E., Vogel, J.A., ten Cate, R., van Lienden, K.P., van Gulik, T.M., Franken, N.A.P., Oei, A.L., Kok, H.P., Besselink, M.G., Crezee, J.

“…Irreversible electroporation (IRE) is an ablation modality that applies short, high-voltage electric pulses to unresectable cancers. Although considered a…”
Get full text

Adjuvant chemotherapy in patients with resected pancreatic cancer following neoadjuvant FOLFIRINOX chemotherapy: an international multicenter study by Van Roessel, S., Van Veldhuisen, E., Jansen, K., Abu Hilal, M., Alseidi, A., Bassi, C., Malleo, G., Del Chiaro, M., Hackert, T., Falconi, M., Mortensen, M., Lesurtel, M., Keck, T., Pietrasz, D., Strobel, O., Tarvainen, T., Van Laarhoven, H., Wilmink, H., Groot Koerkamp, B., Besselink, M.

Get full text

Fixed vs Targeted Protocol during CT-guided IRE in Locally Advanced and Recurrent Pancreatic Cancer Following Induction Chemotherapy: A Randomized Phase II Trial by Doppenberg, D., van Veldhuisen, E., Agnass, P., Crezee, J., Hurks, R., van Lienden, K., Wilmink, J., Zijlstra, I., van Delden, O., Besselink, M.

Get full text

Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment by van Roessel, Stijn, van Veldhuisen, Eran, Klompmaker, Sjors, Janssen, Quisette P, Abu Hilal, Mohammed, Alseidi, Adnan, Balduzzi, Alberto, Balzano, Gianpaolo, Bassi, Claudio, Berrevoet, Frederik, Bonds, Morgan, Busch, Olivier R, Butturini, Giovanni, Del Chiaro, Marco, Conlon, Kevin C, Falconi, Massimo, Frigerio, Isabella, Fusai, Giuseppe K, Gagnière, Johan, Griffin, Oonagh, Hackert, Thilo, Halimi, Asif, Klaiber, Ulla, Labori, Knut J, Malleo, Giuseppe, Marino, Marco V, Mortensen, Michael B, Nikov, Andrej, Lesurtel, Mickaël, Keck, Tobias, Kleeff, Jörg, Pandé, Rupaly, Pfeiffer, Per, Pietrasz, D, Roberts, Keith J, Sa Cunha, Antonio, Salvia, Roberto, Strobel, Oliver, Tarvainen, Timo, Bossuyt, Patrick M, van Laarhoven, Hanneke W M, Wilmink, Johanna W, Groot Koerkamp, Bas, Besselink, Marc G

“…The benefit of adjuvant chemotherapy after resection of pancreatic cancer following neoadjuvant combination treatment with folinic acid, fluorouracil,…”
Get more information

CA19-9 response and CT-imaging predict resectability of locally advanced pancreatic carcinoma following neoadjuvant chemotherapy by van Veldhuisen, E., Vogel, J.A., Busch, O.R., Wilmink, J.W., van Lienden, K.P., Marsman, H.A., Besselink, M.G.

Get full text

CA19-9 response and CT-imaging predict resectability of locally advanced pancreatic carcinoma following neoadjuvant chemotherapy by van Veldhuisen, E., Vogel, J.A., Busch, O.R., Wilmink, J.W., van Lienden, K.P., Marsman, H.A., Besselink, M.G.

Get full text

Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort Study by van Veldhuisen, Eran, Klompmaker, Sjors, Janssen, Quisette P., Hilal, Mohammed Abu, Alseidi, Adnan, Balduzzi, Alberto, Balzano, Gianpaolo, Bassi, Claudio, Berrevoet, Frederik, Bonds, Morgan, Busch, Olivier R., Butturini, Giovanni, Conlon, Kevin C., Frigerio, Isabella M., Fusai, Giuseppe K., Gagnière, Johan, Griffin, Oonagh, Hackert, Thilo, Halimi, Asif, Keck, Tobias, Kleeff, Jörg, Klaiber, Ulla, Labori, Knut J., Lesurtel, Mickael, Malleo, Giuseppe, Marino, Marco V., Molenaar, I. Quintus, Mortensen, Michael B., Nikov, Andrej, Pagnanelli, Michele, Pandé, Rupaly, Pfeiffer, Per, Pietrasz, Daniel, Rangelova, Elena, Roberts, Keith J., Cunha, Antonio Sa, Salvia, Roberto, Strobel, Oliver, Tarvainen, Timo, Wilmink, Johanna W., Koerkamp, Bas Groot, Besselink, Marc G.

“…Background Preoperative FOLFIRINOX chemotherapy is increasingly administered to patients with borderline resectable (BRPC) and locally advanced pancreatic…”
Get full text

Added Value of 3T-MRI in Assessing Locally Advanced Pancreatic Cancer Following Induction Chemotherapy (IMAGE-MRI): Prospective Single Center Pilot Study by Stoop, T.F., van Veldhuisen, E., van Rijssen, L.B., Klaassen, R., Gurney-Champion, O.J., de Hingh, I.H., Busch, O.R., van Laarhoven, H.W., van der Lienden, K.P., Wilmink, J.W., Nio, C.Y., Nederveen, A.J., Engelbrecht, M.R., Besselink, M.G.

Get full text

Added Value of Ultrasound during Surgical Exploration in Patients with Pancreatic Cancer and Arterial and Venous Vascular Involvement (ULTRAPANC) – A Prospective Multicenter Study by Michiels, N., Doppenberg, D., Groen, J., Bonsing, B., Busch, O., Crobach, S., van Delden, O., van Dieren, S., Farina Sarasqueta, A., de Hingh, I., Hurks, R., Nederend, J., Festhali, S., Tank, Y., van Veldhuisen, E., Wasser, M., Besselink, M., Mieog, S.

Get full text

Time-dependent impact of irreversible electroporation on pancreas, liver, blood vessels and nerves: a systematic review of experimental studies by Vogel, J.A., van Veldhuisen, E., Agnass, P.A., Crezee, J., Dijk, F., Verheij, J., van Gulik, T.M., Meijerink, M.R., Vroomen, L.G., van Lienden, K.P., Besselink, M.G.

Get full text

Time-dependent impact of irreversible electroporation on pancreas, liver, blood vessels and nerves: a systematic review of experimental studies by Vogel, J.A., van Veldhuisen, E., Agnass, P.A., Crezee, J., Dijk, F., Verheij, J., van Gulik, T.M., Meijerink, M.R., Vroomen, L.G., van Lienden, K.P., Besselink, M.G.

Get full text

Survival and complications of pancreatectomy following FOLFIRINOX chemotherapy in borderline resectable and locally advanced pancreatic cancer: A pan-European cohort by Van Veldhuisen, E., Klompmaker, S., Janssen, Q., Hilal, M Abu, Bassi, C., Busch, O., Del Chiaro, M., Wilmink, J., Molenaar, I., Lesurtel, M., Keck, T., Kleeff, J., Salvia, R., Strobel, O., Koerkamp, B Groot, Besselink, M.

Get full text

Readily available biomarkers can help to identify patients with worst prognosis in metastatic pancreatic cancer by Strijker, M., Van Veldhuisen, E., Van der Geest, L., Busch, O., Mohammad, N Haj, Homs, M., Van Hooft, J., Lemmens, V., Verheij, J., De Vos-Geelen, J., Wilmink, J., Besselink, M., Van Laarhoven, H.

Get full text

Intra-operative ultrasound to determine resecability during surgical exploration of primary non-resectable pancreatic cancer following induction chemotherapy by van Veldhuisen, E., Walma, M.S., van Rijssen, L.B., Busch, O.R., van Laarhoven, H.W., van Leeuwen, M.S., Wilmink, J.W., Molenaar, I.Q., Besselink, M.G., van Lienden, K.P.

Get full text

Radiofrequency ablation and irreversible electroporation in locally advanced pancreatic cancer: competitive or complementary treatment modalities? by Walma, M., Vogel, J., van Veldhuisen, E., Busch, O., Wilmink, H., van Santvoort, H., Besselink, M., Molenaar, Q., van Lienden, K.

Get full text

Time-dependent impact of irreversible electroporation on pancreas, liver, blood vessels and nerves: a systematic review of experimental studies by Vogel, J., van Veldhuisen, E., Agnass, P., Crezee, J., Dijk, F., Verheij, J., van Gulik, T., Meijerink, M., Vroomen, L., van Lienden, K., Besselink, M.

Get full text